RUNX1–Survivin Axis Is a Novel Therapeutic Target for Malignant Rhabdoid Tumors

Malignant rhabdoid tumor (MRT) is a highly aggressive pediatric malignancy with no effective therapy. Therefore, it is necessary to identify a target for the development of novel molecule-targeting therapeutic agents. In this study, we report the importance of the runt-related transcription factor 1...

Descripción completa

Detalles Bibliográficos
Autores principales: Mikami, Masamitsu, Masuda, Tatsuya, Kanatani, Takuya, Noura, Mina, Umeda, Katsutsugu, Hiramatsu, Hidefumi, Kubota, Hirohito, Daifu, Tomoo, Iwai, Atsushi, Hattori, Etsuko Yamamoto, Furuichi, Kana, Takasaki, Saho, Tanaka, Sunao, Matsui, Yasuzumi, Matsuo, Hidemasa, Hirata, Masahiro, Kataoka, Tatsuki R., Nakahata, Tatsutoshi, Kuwahara, Yasumichi, Iehara, Tomoko, Hosoi, Hajime, Imai, Yoichi, Takita, Junko, Sugiyama, Hiroshi, Adachi, Souichi, Kamikubo, Yasuhiko
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Molecular and Cellular Biology 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9794559/
https://www.ncbi.nlm.nih.gov/pubmed/36572559
http://dx.doi.org/10.14348/molcells.2022.2031

Ejemplares similares

Ejemplares similares